```html

Water‑pipe (Hookah) Lung Injury

Overview

Water‑pipe lung injury, sometimes called hookah‑related lung disease or e‑cigarette or vaping product use‑associated lung injury (EVALI) when it involves vaping liquids, refers to an acute or sub‑acute inflammation of the lung tissue that occurs after inhalation of toxic substances from a hookah (also known as shisha, water‑pipe or narghile). The injury can range from mild bronchitis to severe, life‑threatening respiratory failure.

Who it affects

• Predominantly young adults (ages 15‑35) who use hookah socially.
• Higher incidence in college students and people of Middle Eastern or South Asian descent where hookah use is culturally normative.
• Both males and females are affected; recent U.S. surveillance shows a slight male predominance (≈55%).

Prevalence

Accurate global rates are difficult to determine because hookah use is often under‑reported. In the United States, the CDC identified over 2,800 cases of EVALI in 2019‑2020, of which roughly 10‑15 % involved flavored or flavored‑tobacco hookah products. In the Middle East, cross‑sectional surveys suggest that up to 30 % of university‑age adults have tried hookah, and 5‑10 % are current regular users, putting millions at risk of respiratory injury.

Symptoms

Symptoms usually appear within 24 hours to 2 weeks after a hookah session, but delayed presentations up to 30 days have been documented.

Respiratory

• Cough – dry or productive, often with sputum that may be yellow‑green.
• Shortness of breath (dyspnea) – may be mild at rest or severe with exertion.
• Wheezing or chest tightness – can mimic asthma.
• Pleuritic chest pain – sharp pain that worsens with breathing.
• Hemoptysis – coughing up blood, rare but a red‑flag sign.

Systemic

• Fever (often low‑grade, 37.8‑38.5 °C)
• Fatigue and malaise
• Headache
• Myalgias (muscle aches)
• Gastro‑intestinal upset – nausea, vomiting, abdominal pain, or diarrhea (seen in up to 30 % of cases).
• Weight loss (if injury becomes chronic).

Physical Findings

• Rapid breathing (tachypnea) – >20 breaths/min.
• Low oxygen saturation (<94 % on room air).
• Crackles (rales) heard on lung auscultation, especially in basal regions.
• Prolonged expiration due to airway obstruction.

Causes and Risk Factors

Hookah smoke is a complex aerosol that contains many of the same toxicants found in cigarette smoke, plus additional hazards introduced by the water‑pipe apparatus.

Key Causative Agents

• Carbon monoxide (CO) – produced by charcoal used to heat the tobacco; binds hemoglobin and reduces oxygen delivery.
• Toxic metals – lead, arsenic, and cadmium can leach from the metal bowl and hoses.
• Volatile organic compounds (VOCs) – formaldehyde, acrolein, and benzene are generated by pyrolysis of the tobacco.
• Polycyclic aromatic hydrocarbons (PAHs) – carcinogenic compounds formed during incomplete combustion.
• Flavoring chemicals – diacetyl, 2,3‑pentadione, and other flavorants have been implicated in bronchiolitis obliterans (“popcorn lung”).
• Microbial contamination – shared mouthpieces can transmit bacteria, fungi, or mycobacteria.

Risk Factors

• Frequency and duration – Daily or binge sessions (>1 hour) dramatically increase exposure.
• Use of flavored tobacco – sweet or fruit flavors encourage deeper inhalation.
• Improper device maintenance – cracked hoses, rusted bowls, or leftover residue can release additional toxins.
• Concurrent smoking – cigarette or e‑cigarette users have additive lung damage.
• Underlying lung disease – asthma, COPD, or recent viral infection heighten susceptibility.
• Immune compromise – HIV, organ transplant, or chronic corticosteroid use.

Diagnosis

Because hookah‑related lung injury mimics many other pulmonary conditions, a systematic approach is essential.

Clinical Evaluation

1. Detailed history – focus on recent hookah use (type of tobacco, charcoal, session length) and other inhalational exposures.
2. Physical exam – look for tachypnea, hypoxia, wheezes, and crackles.

Laboratory Tests

• Arterial blood gas (ABG) – assesses oxygenation and acid‑base status.
• Complete blood count (CBC) – may show leukocytosis.
• Serum carbon monoxide level – elevated COHb (>5 %) supports recent charcoal exposure.
• Inflammatory markers – C‑reactive protein (CRP) and erythrocyte sedimentation rate (ESR) often elevated.
• Microbiology – sputum culture, viral PCR, and Mycobacterium testing to rule out infection.

Imaging

• Chest X‑ray – typically shows bilateral, diffuse infiltrates; may be normal early on.
• High‑resolution CT (HRCT) scan – gold standard; findings include ground‑glass opacities, subpleural sparing, interlobular septal thickening, and “crazy‑paving” pattern.

Pulmonary Function Tests (PFTs)

When the patient is stable, spirometry often demonstrates a mixed obstructive‑restrictive pattern with reduced diffusing capacity (DLCO).

Bronchoscopy (Selective)

Reserved for severe or atypical cases. Bronchoalveolar lavage (BAL) can identify lipid‑laden macrophages, eosinophils, or infectious agents, and helps exclude alternative diagnoses such as eosinophilic pneumonitis.

Diagnostic Criteria (Consensus)

Based on CDC/EVALI guidelines, a probable hookah‑related lung injury diagnosis requires:

1. Use of a water‑pipe within 90 days of symptom onset.
2. Pulmonary infiltrates on imaging.
3. Absence of an alternative plausible diagnosis (infection, cardiac, etc.).
4. Improvement after cessation of hookah use and/or corticosteroid therapy.

Treatment Options

Treatment is largely supportive, with a focus on reducing inflammation and preventing complications.

Immediate Care

• Oxygen supplementation – titrated to maintain SpO₂ ≥ 94 % (≥ 88 % in chronic COPD).
• Bronchodilators – short‑acting β2‑agonists (e.g., albuterol) for wheezing.
• Intravenous fluids – to maintain euvolemia.

Corticosteroids

Systemic steroids are the cornerstone of therapy:

• Prednisone 40–60 mg orally daily for 5–7 days, then tapered over 2–4 weeks.
• Severe cases may require IV methylprednisolone 1–2 mg/kg/day.
• Evidence from retrospective case series (e.g., Lancet Respiratory Medicine, 2022) shows faster radiographic resolution and shorter hospital stay with steroids.

Antibiotics

Empiric antibiotics are often started until infection is excluded, given overlapping clinical pictures.

Mechanical Ventilation

Indicated for respiratory failure (PaO₂ < 60 mmHg or PaCO₂ > 50 mmHg with acidosis). Lung‑protective ventilation (tidal volume 6 mL/kg predicted body weight) reduces ventilator‑induced injury.

Adjunctive Therapies

• N‑acetylcysteine (NAC) – antioxidant; limited data but may improve mucus clearance.
• Pulmonary rehabilitation – early mobilization, breathing exercises.

Lifestyle Changes

Permanent cessation of hookah, cigarette, and vaping products is mandatory to prevent recurrence.

Living with Water‑pipe (Hookah) Lung Injury

Recovery can take weeks to months. The following strategies help individuals manage daily life while the lungs heal.

Self‑Monitoring

• Track symptoms in a diary (cough, dyspnea, sputum color).
• Use a pulse oximeter at home; seek care if SpO₂ falls below 92 %.

Breathing Techniques

• Pursed‑lip breathing – prolongs exhalation and reduces air‑trapping.
• Diaphragmatic breathing – improves ventilation efficiency.

Physical Activity

Start with low‑impact exercises (walking, stationary cycling) and gradually increase intensity as tolerated. Aim for at least 150 minutes of moderate activity per week, per WHO guidelines.

Nutrition

• High‑protein diet (1.2‑1.5 g/kg body weight) supports tissue repair.
• Antioxidant‑rich foods (berries, leafy greens, nuts) may counter oxidative stress.
• Stay hydrated – 2–3 L of water daily unless fluid‑restricted.

Medication Adherence

Complete the steroid taper even if symptoms improve; abrupt cessation can cause rebound inflammation.

Psychosocial Support

• Consider counseling or support groups for tobacco‑cessation.
• Mind‑body practices (yoga, meditation) can reduce anxiety related to breathing difficulties.

Prevention

Because the injury is directly linked to toxic inhalation, prevention centers on eliminating exposure.

Individual Strategies

• Never use a water‑pipe, especially with charcoal‑heated tobacco.
• If you must use hookah socially, limit sessions to <30 minutes and avoid flavored additives that encourage deep inhalation.
• Choose electric heating elements (which eliminate charcoal CO) — but note that vaporized liquids still contain harmful chemicals.
• Never share mouthpieces; use personal, disposable tips.
• Maintain the device: replace hoses, clean the bowl, and discard rusted metal parts.

Public Health Measures

• Regulations on flavored tobacco and charcoal sales (e.g., FDA bans).
• Educational campaigns on campus and in community centers highlighting respiratory risks.
• Implementation of smoke‑free policies in indoor public spaces. (CDC, 2023)

Complications

If left untreated or if exposure continues, several serious complications may develop.

• Acute respiratory distress syndrome (ARDS) – rapid, severe hypoxemia requiring ventilatory support.
• Bronchiolitis obliterans – irreversible airway fibrosis leading to fixed airflow obstruction.
• Secondary bacterial pneumonia – due to impaired mucociliary clearance.
• Pneumothorax – air leak from over‑inflated alveoli.
• Chronic obstructive pulmonary disease (COPD) – accelerated decline in lung function.
• Pulmonary hypertension – long‑term vascular remodeling.
• Increased risk of lung cancer – cumulative exposure to PAHs and nitrosamines.

When to Seek Emergency Care

Early medical attention can dramatically improve outcomes and reduce the likelihood of permanent lung damage.

---

Sources: Mayo Clinic, CDC, NIH National Heart, Lung, and Blood Institute, WHO, Cleveland Clinic, Lancet Respiratory Medicine (2022), JAMA Network Open (2021).

```